OasisLMS

Member only benefit! Results of a recent survey sent to US based practicing urologists show that there has been an increase in the number of advanced practice providers (APPs) actively providing front-line urologic care. Based on these findings, it was determined that the AUA develop a modular curriculum to be used in advancing the standard of urologic education for APPs. This educational curriculum, developed in partnership with the Cleveland Clinic, is comprised of online videos targeted towards the most common reasons patients seek non-operative urologic care. This module provides APPs with an overview of sexually transmitted diseases and prostatitis.

• Physician Assistants
• Advanced Practice Nurses

At the conclusion of this activity, participants will be able to:

1. Classify STI's according to clinical presentation.
2. Utilize the appropriate diagnostic tests based on clinical presentation in regards to STI's.
3. Identify the guideline approved antibiotics for each STI.
4. Describe the current classification system for prostatitis syndromes.
5. Diagnose patients suffering from prostatitis based on clinical presentation.
6. Utilize the UPOINT system to classify and treat men with chronic pelvic pain.

Education Council Disclosures: Education Council Disclosures (2026)

COI Work Group Disclosures: COI Work Group Disclosures (2026)

Advanced Practice Providers Committee Disclosures: APP Committee Disclosures (2026) 

Faculty Disclosures:

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

METHOD OF PARTICIPATION: Learners will participate in this online educational activity by taking the pretest, viewing the online module and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 0.50 hours

Original Release Date: August, 2023
Renew Date: August, 2026
Expiration Date: August, 2029

ACCREDITATION: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: The American Urological Association designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit^TM.

EVIDENCE BASED CONTENT: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: All persons in a position to control the content of a CME activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible company (formerly commercial interests) during the previous 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The AUA must determine if the individual’s relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of relevant financial relationships that result in conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

DISCLAIMER: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA. 

REPRODUCTION PERMISSION: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

ATTENTION: You are prohibited from using or uploading content you accessed through this activity into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.